Record numbers of biotechs are going public. Here's how they're performing.
Bio Pharma Dive
OCTOBER 26, 2020
Initial public offerings have fueled biotech's boom. A new database built by BioPharma Dive will help you keep track of them as they happen.
Sat.Oct 24, 2020 - Fri.Oct 30, 2020
361 
Web analytics should tell a story
World of DTC Marketing
OCTOBER 30, 2020
IN SUMMARY: Web analytics really has nothing to do with numbers. They have everything to do with what the numbers are telling you about your audience and messaging. DTC marketers need to get out of the mindset of using raw numbers and ask their web analytics people for insights instead. One of the services we often provide for clients is a deep-dive web analytics report.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Oxford start-up Base Genomics acquired by Exact Sciences
Pharma Times
OCTOBER 28, 2020
Acquisition will enable Base Genomics to accelerate clinical and commercial development
Singapore Halts Dosing of Two Flu Shots After 59 Deaths in South Korea
BioSpace
OCTOBER 27, 2020
South Korea, on the other hand, indicated they would continue their state-run vaccination program because they did not find a direct link between the deaths and the vaccinations.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Atea, riding interest in COVID-19 drugs, pulls off one of 2020's top biotech IPOs
Bio Pharma Dive
OCTOBER 30, 2020
The Boston startup's initial public offering is the fourth-largest in biotech this year, according to data compiled by BioPharma Dive.
Health consumers: A long way off
World of DTC Marketing
OCTOBER 27, 2020
We keep hearing the term “consumers of health” but the American healthcare system is too profitable to allow people to be consumers of healthcare. “The need for action now is clear. Health care costs are climbing so fast they may soon threaten the quality of care and access to care which Americans enjoy.” Ronald Reagan. What if … people got a fair ROI for healthcare spending the way we expect a reasonable return from other investments?
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Study Suggests COVID-19 Infection Could Age the Brain, Reduce Cognition
BioSpace
OCTOBER 27, 2020
The report showed that in some cases, people who have recovered from the virus continued to exhibit significant cognitive deficits.
Mirati cancer drug results spark hopes of outperforming Amgen's
Bio Pharma Dive
OCTOBER 26, 2020
The biotech's KRAS-blocking pill trails Amgen's sotorasib in development, but early data suggest it might match the bar set by Amgen.
Leaders must make their organizations and the world better
World of DTC Marketing
OCTOBER 28, 2020
SUMMARY: Leaders have a duty to make their companies stronger and help make the world a better place. Leadership is crucial in providing a unified vision. Pharma CEO’s shouldn’t believe that their products, alone, will help make the world a stronger place. People want and need more. I believe there is a significant leadership vacuum in healthcare.
Pharma 2030: Will payers fund more preventive care programmes?
pharmaphorum
OCTOBER 26, 2020
Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake. A new analysis looks at these barriers and asks how they could be overcome. Over the past decade, many healthcare systems have worked to expand their focus on health maintenance and disease prevention as several studies have indicated that preventive care services can play a significant role in improving general health while helping reduce long term healthcare costs.
COVID-19 by the Numbers: Mortality Rates in U.S. Decrease, Despite Uptick in Cases
BioSpace
OCTOBER 27, 2020
The number of excess deaths in the United States is trending downward despite autumn upticks in COVID-19 incidents.
Bristol Myers taps machine-learning biotech for help finding ALS drugs
Bio Pharma Dive
OCTOBER 28, 2020
The companies hope Insitro's technology can lead to a deeper understanding of how ALS progresses and, in turn, help them discover better treatments.
Unfair balance
World of DTC Marketing
OCTOBER 29, 2020
WHAT’S UP? : It’s time to admit that the FDA is completely out of touch regarding DTC advertising. Fair balance is not being read in ads or listened to on TV, and the language used in fair balance is too often complicated for online health seekers. I just finished an analysis of a pharma clients website using their analytics. Rather than just report the numbers my report “tells a story” that managers can use to justify changes to the product website.
Why Sneeze Guards are Not Optional Anymore
Pharma Mirror
OCTOBER 30, 2020
The sneeze guard has been keeping employees at public counters, and food on display, safe from contagious diseases for a long time now, so it’s most certainly not a new invention. However, the need to install a sneeze guard in hospitals, pharmacies and other healthcare facilities is an absolute must in 2020 and beyond. Keeping. The post Why Sneeze Guards are Not Optional Anymore appeared first on Pharma Mirror Magazine.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Ipsen’s UK MD on adapting business to COVID-19
pharmaphorum
OCTOBER 30, 2020
Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining global biopharma Ipsen. He tells us how the company has responded to COVID and how he’d like to see the UK industry grow in the future. As managing director, Ipsen UK & Ireland, Ali heads up one of Ipsen’s three global hubs, as well as chairing a UK & Ireland Site Steering Committee overseeing 900 peop
5 takeaways from the FDA's closely watched coronavirus vaccine meeting
Bio Pharma Dive
OCTOBER 24, 2020
Experts convened by the regulators debated how much data would warrant an approval, while pressing government officials on their distribution plans.
IQVIA: tap the right talent to lead digital transformation
Outsourcing Pharma
OCTOBER 30, 2020
In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.
Temperature monitoring solutions provider TSS shares news on new appointment for Middle East operations
Pharma Mirror
OCTOBER 30, 2020
Leading cloud temperature management solutions provider, TSS Middle East, today announces the appointment of Christopher Hobeiche as the new regional manager for their Middle East operations. Christopher Hobeiche joined the TSS Middle East Africa team earlier this month as part of strategic efforts to strengthen company operations in the region. TSS provides temperature monitoring solutions.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Regeneron Halts Enrollment of Critically Ill Patients in COVID-19 Antibody Trial
BioSpace
OCTOBER 29, 2020
The decision to halt critically ill patients was made in response to Regeneron’s independent safety board finding a potential safety signal and an unfavorable risk-benefit profile of the monoclonal antibody therapy in a subgroup of patients requiring high-flow oxygen or mechanical ventilation.
Axovant shares sink on manufacturing delay for Parkinson's gene therapy
Bio Pharma Dive
OCTOBER 30, 2020
A longer-than-expected timeline for developing a new manufacturing process means a key study for Axovant's top gene therapy likely won't begin until 2022.
Why 72% of patients don’t feel listened to by pharma
pharmaphorum
OCTOBER 28, 2020
Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.
AZ’s Fasenra hits the mark in phase IIIb asthma trial
Pharma Times
OCTOBER 30, 2020
Drug significantly eliminated oral corticosteroid (OCS) in OCS-dependent asthma patients
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pfizer Enters Final Stretch of Late-Stage COVID-19 Vaccine Trial
BioSpace
OCTOBER 27, 2020
Pfizer indicated yesterday that its Phase III clinical trial of 44,000 volunteers now needs fewer than 2,000 people to be fully enrolled.
US to pay Lilly $375M for supply of COVID-19 drug
Bio Pharma Dive
OCTOBER 28, 2020
Lilly will charge the U.S. $1,250 per vial of the antibody-based treatment, which is under review by the FDA for an emergency approval.
What can we learn from women’s health data?
pharmaphorum
OCTOBER 27, 2020
Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments.
UK biotech consortium identifies COVID-19 antibody combinations
Pharma Times
OCTOBER 30, 2020
The UK BIA Antibody Taskforce is set to take combinations into further development as a cocktail
Exact Sciences to Acquire Thrive in Deal Valued at $2.15 Billion
BioSpace
OCTOBER 27, 2020
The deal, which is worth up to $2.15 billion, is expected to close in the first quarter of 2021 and is subject to regulatory approval.
Safety concerns lead Regeneron to halt testing of COVID-19 drug in some patients
Bio Pharma Dive
OCTOBER 30, 2020
A study monitoring board flagged a "potential safety signal" in some hospitalized COVID-19 patients who require breathing support, telling the biotech to modify its study protocol.
Giving the immune system a double boost against cancer
Scienmag
OCTOBER 30, 2020
Credit: CSHL, 2020 Cancer immunotherapies, which empower patients’ immune systems to eliminate tumors, are revolutionizing cancer treatment. Many patients respond well to these treatments, sometimes experiencing long-lasting remissions. But some cancers remain difficult to treat with immunotherapy, and expanding the impact of the approach is a high priority.
Blood test more predictive of ovarian cancer than ‘previously thought’
Pharma Times
OCTOBER 30, 2020
Findings come from new research funded by Cancer Research UK and NIHR
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content